PL366885A1 - Sposób wytwarzania krystalicznej formy alfa soli addycyjnej kwasu metanosulfonowego i 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2-yloamino]fenylo]benzamidu - Google Patents

Sposób wytwarzania krystalicznej formy alfa soli addycyjnej kwasu metanosulfonowego i 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2-yloamino]fenylo]benzamidu

Info

Publication number: PL366885A1
Authority: PL; Poland
Prior art keywords: methyl; methylpiperazin; benzamide; pyrimidin; pyridin
Prior art date: 2004-04-02

Application number

PL04366885A

Other languages

English (en)

Other versions

PL216883B1 (pl

Inventor

Wojciech Szczepek

Dorota Samson-Łazińska

Bogdan Zagrodzki

Magdalena Glice

Wioleta Maruszak

Katarzyna Korczak

Łukasz Kaczmarek

Wiesław Szelejewski

Original Assignee

Instytut Farmaceutyczny

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-02

Filing date

2004-04-02

Publication date

2005-10-03

2004-04-02 Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny

2004-04-02 Priority to PL366885A priority Critical patent/PL216883B1/pl

2005-02-04 Priority to UAA200611573A priority patent/UA84462C2/ru

2005-04-02 Priority to PCT/PL2005/000024 priority patent/WO2005095379A2/en

2005-04-02 Priority to EP05731354A priority patent/EP1742933A2/en

2005-04-02 Priority to US10/599,461 priority patent/US7732601B2/en

2005-10-03 Publication of PL366885A1 publication Critical patent/PL366885A1/pl

2006-09-14 Priority to IL178097A priority patent/IL178097A/en

2014-05-30 Publication of PL216883B1 publication Critical patent/PL216883B1/pl

Links

KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title 2
239000002253 acid Substances 0.000 title 1
239000000654 additive Substances 0.000 title 1
230000000996 additive effect Effects 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

PL366885A 2004-04-02 2004-04-02 Sposób wytwarzania krystalicznej formy a soli addycyjnej kwasu metanosulfonowego i 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2- -yloamino)fenylo]benzamidu PL216883B1 (pl)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
PL366885A PL216883B1 (pl)	2004-04-02	2004-04-02	Sposób wytwarzania krystalicznej formy a soli addycyjnej kwasu metanosulfonowego i 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2- -yloamino)fenylo]benzamidu
UAA200611573A UA84462C2 (ru)	2004-04-02	2005-02-04	Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой
PCT/PL2005/000024 WO2005095379A2 (en)	2004-04-02	2005-04-02	Crystalline methanesulfonic acid addition salts of imatinib
EP05731354A EP1742933A2 (en)	2004-04-02	2005-04-02	Crystalline methanesulfonic acid addition salts of imatinib
US10/599,461 US7732601B2 (en)	2004-04-02	2005-04-02	Crystalline polymorphs of methanesulfonic acid addition salts of Imatinib
IL178097A IL178097A (en)	2004-04-02	2006-09-14	Polymorphs of IMATINIB acid addition salts with tensulfonic acid

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL366885A PL216883B1 (pl)	2004-04-02	2004-04-02	Sposób wytwarzania krystalicznej formy a soli addycyjnej kwasu metanosulfonowego i 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2- -yloamino)fenylo]benzamidu

Publications (2)

Publication Number	Publication Date
PL366885A1 true PL366885A1 (pl)	2005-10-03
PL216883B1 PL216883B1 (pl)	2014-05-30

Family

ID=36645532

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL366885A PL216883B1 (pl)	2004-04-02	2004-04-02	Sposób wytwarzania krystalicznej formy a soli addycyjnej kwasu metanosulfonowego i 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2- -yloamino)fenylo]benzamidu

Country Status (1)

Country	Link
PL (1)	PL216883B1 (pl)

2004
- 2004-04-02 PL PL366885A patent/PL216883B1/pl not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL216883B1 (pl)	2014-05-30

Similar Documents

Publication	Publication Date	Title
TWI347186B (en)	2011-08-21	Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
IL223350A0 (en)	2013-02-03	Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
ZA200804030B (en)	2009-02-25	Improved process for the preparation of 4-(benzimidazolylmethylamino)benzamides and the salts thereof
IL183526A0 (en)	2007-09-20	4-(4-(imidazol-4-yl)pyrimidin-2-ylamino)benzamides as cdk inhibitors
DK1794126T3 (da)	2013-06-24	Krystallinsk form af N-(-4-fluorbenzyl)-N-(1-methylpiperidn-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamid-hemitartrat
IL164678A (en)	2014-02-27	High-drug tablet containing 4– (4-methylpiprazine – 1-ylamethyl) -n - [(4-methyl-3– (4-pyridin-3-il) pyrimidine-2-ylamino) phenyl] -benzamide or compatible salt Its pharmaceutical and process for its preparation
HRP20161751T1 (hr)	2017-04-07	Kinazolinoni kao inhibitori humane fosfatidilinozitol 3-kinaze delta
IL181169A0 (en)	2007-07-04	Trifluoromethyl substituted benzamides as kinase inhibitors
IL181811A0 (en)	2007-07-04	Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
UY29766A1 (es)	2007-03-30	Formas cristalinas delta y épsilon de mesilato de imatinib
ZA200703440B (en)	2008-08-27	Novel crystalline form of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenthyl)-piperazine-1-yl]-methanone hydrochloride
NO20054763D0 (no)	2005-10-17	Salts of clopidogrel and process for preparation
WO2009065910A3 (en)	2009-12-30	Acid addition salts of imatinib and formulations comprising the same
PH12014501062A1 (en)	2014-06-23	Immediate release 4-methyl-3-[[4-(3-pyridinyl )-2-pyrimidinyl ]amino]-n-[5-(4-methyl-1h-1midazol-1yl)-3-(trifluoromethyl)phenyl]benzamide formulation
PL366885A1 (pl)	2005-10-03	Sposób wytwarzania krystalicznej formy alfa soli addycyjnej kwasu metanosulfonowego i 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2-yloamino]fenylo]benzamidu
HUE037259T2 (hu)	2018-08-28	N-alfa(2,4,6-triizopropil-fenil-szulfonil)-3-hidroxi-amidino-(L)-fenilalanin-4-etoxi-karbonilpiperazid és/vagy sóinak kristályos módosulatai
DE602005007871D1 (de)	2008-08-14	8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4-methoxyphenyl)-1-methylethylü amino üäethyl -2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür
AU2003297640A8 (en)	2004-06-23	Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
ZA200705073B (en)	2009-05-27	4-(4-(imidazol-4-yl)pyrimidin-2-ylamino) benzamides as CDK inhibitors
IL180486A0 (en)	2007-06-03	Salts of benzimidazole derivative with amines and process for production thereof
IL174040A0 (en)	2006-08-01	Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases
PL374074A1 (pl)	2006-10-02	Sposób wytwarzania krystalicznej formy Ó monomesylanu 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2-yloamino]fenylo]benzamidu
ZA200709776B (en)	2008-11-26	Inhibitors of microsomal triglyceride transfer protein and Apo-B secretion
PL387516A1 (pl)	2010-09-27	Kompozycja farmaceutyczna zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję
DE60318319D1 (de)	2008-02-07	Verfahren zur herstellung von modifikation i von n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3 pyridinsulfonamid

Legal Events

Date	Code	Title	Description
2015-02-27	LAPS	Decisions on the lapse of the protection rights	Effective date: 20130402